Dihydropyridine calcium antagonists depress the amplitude of the plasma melatonin cycle in baboons.
An investigation into the effects of verapamil and some dihydropyridine derivatives on plasma melatonin levels was undertaken in baboons. In a number of separate experiments, groups of young male chacma baboons (mean body weight 13 kg) received intraperitoneal injections of the drugs, under ketamine anaesthesia, roughly 30 minutes prior to the following time points: 1200, 1800, 0000, 0200, 0600 and 1200 h. Lights went off at 1800 h and came on at 0600 h. The drugs used, and their respective dosages (expressed per kg body mass), were verapamil up to 4 mg/kg, nifedipine at 0.2 mg/kg, nitrendipine at 0.5 mg/kg and nisoldipine at 0.1 mg/kg. Blood samples, taken at the said time points, were assayed for melatonin. The nighttime peak of the plasma melatonin cycle was significantly depressed by all three dihydropyridine calcium antagonists (up to 40%), while verapamil, even at the relatively high total dose of 24 mg/kg per day, had no significant effect on the circulating plasma melatonin levels.
D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D008297:Male; D008550:Melatonin / Q000097:blood*; D009543:Nifedipine / Q000031:analogs & derivatives / Q000494:pharmacology; D015737:Nisoldipine; D009568:Nitrendipine / Q000494:pharmacology; D010215:Papio; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D015737:Nisoldipine; D009568:Nitrendipine; D014700:Verapamil; D009543:Nifedipine; D008550:Melatonin